Latest Developments in Global Genital Warts Treatment Market

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Genital Warts Treatment Market

  • Pharmaceutical
  • Upcoming Report
  • Nov 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In December 2023, Padagis, a pharmaceutical company, received U.S. FDA approval to market Podofilox Gel, the first generic version of Condylox Gel 0.5%, in the United States. This topical antimitotic medication is used for treating anogenital warts, including external genital and perianal warts. The approval marks a significant step in providing a more affordable treatment option for patients in the U.S
  • In January 2023, Verrica Pharmaceuticals announced receiving the meeting minutes from its Type C meeting with the FDA, held on November 6, 2023. The meeting focused on discussing the Phase 3 clinical development plan for YCANTH as a treatment for common warts. Verrica is optimistic that the meeting helped align on the pivotal Phase 3 study design, which is essential for expanding YCANTH’s indication, currently approved for molluscum contagiosum, to include common warts, pending further clinical trials

Frequently Asked Questions

The market is segmented based on Segmentation, By Therapy (Prevention and Treatment), Drug (Imiquimod, Podophyllin and Podofilox, Trichloroacetic Acid, Sinecatechins, and Others), Route of Administration (Parenteral and Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Industry Trends and Forecast to 2032 .
The Global Genital Warts Treatment Market size was valued at USD 1.91 USD Billion in 2024.
The Global Genital Warts Treatment Market is projected to grow at a CAGR of 5.8% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..